9DOU image
Deposition Date 2024-09-19
Release Date 2025-05-21
Last Version Date 2025-07-16
Entry Detail
PDB ID:
9DOU
Title:
Taeniopygia guttata R2 retrotransposon (R2Tg) initiating target-primed reverse transcription
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
3.20 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:R2Tg retrotransposon ORF
Chain IDs:A
Chain Length:1390
Number of Molecules:1
Biological Source:Taeniopygia guttata
Polymer Type:polydeoxyribonucleotide
Molecule:28S DNA bottom strand, 3' side
Chain IDs:B
Chain Length:211
Number of Molecules:1
Biological Source:Taeniopygia guttata
Polymer Type:polydeoxyribonucleotide
Molecule:28S DNA bottom strand, 5' side (priming strand)
Chain IDs:C (auth: P)
Chain Length:13
Number of Molecules:1
Biological Source:Taeniopygia guttata
Polymer Type:polyribonucleotide
Molecule:R2Tg 3'UTR RNA
Chain IDs:D (auth: R)
Chain Length:333
Number of Molecules:1
Biological Source:Taeniopygia guttata
Polymer Type:polydeoxyribonucleotide
Molecule:28S DNA top strand
Chain IDs:E (auth: T)
Chain Length:211
Number of Molecules:1
Biological Source:Taeniopygia guttata
Primary Citation
Structure and biochemistry-guided engineering of an all-RNA system for DNA insertion with R2 retrotransposons.
Nat Commun 16 6079 6079 (2025)
PMID: 40603868 DOI: 10.1038/s41467-025-61321-z

Abstact

R2 elements, a class of non-long terminal repeat (non-LTR) retrotransposons, have the potential to be harnessed for transgene insertion. However, efforts to achieve this are limited by our understanding of the retrotransposon mechanisms. Here, we structurally and biochemically characterize R2 from Taeniopygia guttata (R2Tg). We show that R2Tg cleaves both strands of its ribosomal DNA target and binds a pseudoknotted RNA element within the R2 3' UTR to initiate target-primed reverse transcription. Guided by these insights, we engineer and characterize an all-RNA system for transgene insertion. We substantially reduce the system's size and insertion scars by eliminating unnecessary R2 sequences on the donor. We further improve the integration efficiency by chemically modifying the 5' end of the donor RNA and optimizing delivery, creating a compact system that achieves over 80% integration efficiency in several human cell lines. This work expands the genome engineering toolbox and provides mechanistic insights that will facilitate future development of R2-mediated gene insertion tools.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback